N,N’-Bis(benzyloxycarbonyl)-L-cystine

We are N,N’-Bis(benzyloxycarbonyl)-L-cystine CAS:6968-11-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: N,N'-Bis(benzyloxycarbonyl)-L-cystine
CAS.NO: 6968-11-2
Molecular Formula:C22H24N2O8S2
Molecular Weight: 508.56500

Synonyms:
DI-CBZ-L-CYST
(DI-Z-CYS-OH)2
DI-Z-L-CYSTINE
(Cbz-L-Cys-OH)2
(CBZ-CYS-OH)2
N,N'-bis(benzyloxycarbonyl)cystine
N,N'-bisbenzilossicarbonil-L-cistina
N,N'-DI-CBZ-L-CYSTINE
N,N'-Bis-Cbz-L-cystine
(Z-L-Cys-OH)2
DI-CBZ-L-CYSTINE
(R,R)-N,N'-dibenzyloxycarbonyl-3,3'-dithiobis(2-aminopropionic acid)
DI-N-CBZ-L-CYSTINE
N,N'-dibenzyloxycarbonyl-L-cystine
N-CBz-L-cystine

Physical and Chemical Properties:
Density: 1.422g / cm3
Boiling point: 766.1ºC at 760 mmHg
Melting point: 118-122 ° C (dec.)
Flash point: 417.1ºC
Refractive index: -91 ° (C = 8.8, AcOH)

Specification:
Appearance: White powder
Purity:≥98%
Loss on drying:0.2% max
Residue on ignition(sulfated):0.10% max

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at RT.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:1. Medicine is to promote the body's cells on the oxidation and reduction function, increase the white blood cells and to prevent pathogenic bacteria growth, and so on.Mainly used for all kinds of alopecia.Also used in acute infectious diseases such as dysentery, typhoid fever, flu, asthma, neuralgia, eczema, as well as a variety of poisoning disease, etc., and maintain the function of protein conformation.Also used as a food flavoring
2. Be feed nutrition enhancer, be helpful for animal growth, increase the weight and liver and kidney function, improve the quality of fur.
3. Can make cosmetic additives, can promote wound healing and prevent skin allergy and treatment effect such as eczema.

Related News: The travel restrictions will take effect on Tuesday, Prime Minister Chung Sye-kyun said, as the number of people testing positive for the coronavirus in South Korea increased to 15.5-O-Tritil-2,3, -anhidrotimidina CAS:25442-42-6 This is how an API becomes a medicine.2128-93-0 This is how an API becomes a medicine.1- (2,3-difluorofenil) etanona CAS:18355-80-1 Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition.Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition.